THE EFFECT OF NIACINAMIDE SUPPLEMENTATION ON PHOSPHATE CONCENTATIONS IN DIALYSIS PATIENTS.

• Conditions: high phosphate level; hyperphospatemia; 10013296; 10038430

• Registration Number: NL-OMON41924
• Lead Sponsor: Ziekenhuis Gelderse Vallei

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

- Hemodialysis patients
- Adults (* 18 year)
- Stable dialysis state (at least 6 months hemodialysis ) as measured at baseline

Exclusion Criteria

- Severely malnourished patients as diagnosed by the dietitian
- Patients who dialyse at night in-hospital
- Language barrier

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the serum phosphate concentrations in week 8 and<br /><br>12.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p> Other study parameters are compliance to phosphate binders and<br /><br>supplement-related complaints such as nausea, diarrhea, flushing and itchiness<br /><br>that leads to dropout.</p><br>